ReviewBritish journal of cancer2016

PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions.

G E Konecny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.